An interpretable deep learning framework for predicting liver metastases in postoperative colorectal cancer patients using natural language processing and clinical data integration
Cancer Medicine · 2023
DOI: 10.1002/cam4.6523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Jia Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Deep Learning, Colorectal Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Science and Technology Commission, Beijing Postdoctoral Science Foundation, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The significance of liver metastasis (LM) in increasing the risk of death for postoperative colorectal cancer (CRC) patients necessitates innovative approaches to predict LM.
Aim
Our study presents a novel and significant contribution by developing an interpretable fusion model that effectively integrates both free‐text medical record data and structured laboratory data to predict LM in postoperative CRC patients.
Methods
We used a robust dataset of 1463 patients and leveraged state‐of‐the‐art natural language processing (NLP) and machine learning techniques to construct a two‐layer fusion framework that demonstrates superior predictive performance compared to single modal models. Our innovative two‐tier algorithm fuses the results from different data modalities, achieving balanced prediction results on test data and significantly enhancing the predictive ability of the model. To increase interpretability, we employed Shapley additive explanations to elucidate the contributions of free‐text clinical data and structured clinical data to the final model. Furthermore, we translated our findings into practical clinical applications by creating a novel NLP score‐based nomogram using the top 13 valid predictors identified in our study.
Results
The proposed fusion models demonstrated superior predictive performance with an accuracy of 80.8%, precision of 80.3%, recall of 80.5%, and an F1 score of 80.8% in predicting LMs.
Conclusion
This fusion model represents a notable advancement in predicting LMs for postoperative CRC patients, offering the potential to enhance patient outcomes and support clinical decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.
- School of Biological Science and Medical Engineering, Beihang University, Beijing, People's Republic of China.
- Department of Radiology, Aerospace Center Hospital, Beijing, People's Republic of China.
ORCID-Profile: Jia Li, Zhenchang Wang, Han Lv
Förderung
- Beijing Municipal Science and Technology Commission
- Beijing Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Li, J., Wang, X., Cai, L., Sun, J., Yang, Z., Liu, W., Wang, Z., & Lv, H. (2023). An interpretable deep learning framework for predicting liver metastases in postoperative colorectal cancer patients using natural language processing and clinical data integration. Cancer Medicine. https://doi.org/10.1002/cam4.6523
Vancouver
Li J, Wang X, Cai L, Sun J, Yang Z, Liu W, et al. An interpretable deep learning framework for predicting liver metastases in postoperative colorectal cancer patients using natural language processing and clinical data integration. Cancer Medicine. 2023. doi:10.1002/cam4.6523
BibTeX
@article{Li2023,
author = {Li, Jia and Wang, Xinghao and Cai, Linkun and Sun, Jing and Yang, Zhenghan and Liu, Wenjuan and Wang, Zhenchang and Lv, Han},
title = {An interpretable deep learning framework for predicting liver metastases in postoperative colorectal cancer patients using natural language processing and clinical data integration},
journal = {Cancer Medicine},
year = {2023},
doi = {10.1002/cam4.6523}
}
EUVIMED